These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 10510313)

  • 1. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
    Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
    Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.
    Pérez DR; Damberger FF; Wüthrich K
    J Mol Biol; 2010 Jul; 400(2):121-8. PubMed ID: 20460128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicken prion tandem repeats form a stable, protease-resistant domain.
    Marcotte EM; Eisenberg D
    Biochemistry; 1999 Jan; 38(2):667-76. PubMed ID: 9888807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
    Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
    Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
    Apetri AC; Vanik DL; Surewicz WK
    Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of Syrian hamster prion protein rPrP(90-231).
    Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
    Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR structure of the mouse prion protein domain PrP(121-231).
    Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
    Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion diseases of humans and animals: their causes and molecular basis.
    Collinge J
    Annu Rev Neurosci; 2001; 24():519-50. PubMed ID: 11283320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.